Cargando…
Cardiovascular risk during hormonal treatment in patients with prostate cancer
The objective of this review is to provide information on cardiovascular risk following androgen-deprivation therapy (ADT) in prostate cancer patients and to suggest potential prevention and management strategies. Androgen deprivation therapy can cause peripheral insulin resistance, increase fat mas...
Autores principales: | Van Poppel, Hein, Tombal, Bertrand |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064405/ https://www.ncbi.nlm.nih.gov/pubmed/21448299 http://dx.doi.org/10.2147/CMR.S16893 |
Ejemplares similares
-
Chemoprevention of prostate cancer with nutrients and supplements
por: Van Poppel, Hendrik, et al.
Publicado: (2011) -
The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis
por: Schubert, Maria, et al.
Publicado: (2012) -
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020) -
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
por: Body, Jean-Jacques, et al.
Publicado: (2018) -
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
por: Tombal, Bertrand, et al.
Publicado: (2012)